MapLight Therapeutics to join Russell 3000, Russell 2000 and Russell Microcap indexes
Source: SeekingAlpha
2025-12-09 13:38:17 ET
More on MapLight Therapeutics, Inc.
- MapLight Therapeutics Starts $100 Million IPO Effort For CNS Treatments
- Potential Bristol Myers rival MapLight seeks $250M in U.S. IPO
- Seeking Alpha’s Quant Rating on MapLight Therapeutics, Inc.
- Historical earnings data for MapLight Therapeutics, Inc.
- Financial information for MapLight Therapeutics, Inc.
Read the full article on Seeking Alpha
For further details see:
MapLight Therapeutics to join Russell 3000, Russell 2000 and Russell Microcap indexes
MapLight Therapeutics Inc.
NASDAQ: MPLT
MPLT Trading
-5.11% G/L:
$19.14 Last:
32,863 Volume:
$18.64 Open:
MPLT Latest News
January 09, 2026 07:00:00 am
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
January 05, 2026 07:00:00 am
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer's Disease Psychosis
December 16, 2025 07:00:00 am
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
MPLT Stock Data
$811,723,560
23,593,977
8.4%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
